[ad_1]
This press release was originally distributed by SBWire
Albany, NY – (SBWIRE) – 01/22/2019 – Meningitis is an inflammation (swelling) of the defenses known as the meninges that cover the brain and spinal cord. Bacterial or viral contamination of the fluid including the brain and spinal cord usually causes swelling. However, wounds, diseases, certain medications and different types of infections can also cause meningitis. Bacterial meningitis is intense and can be fatal. In addition, bacterial meningitis can lead to permanent disabilities, such as brain damage and hearing loss, if left untreated. However, the vast majority of meningitis can be prevented with proper vaccination. Streptococcal pneumonia, neisseria meningitis and listeria monocytogenes are among the bacteria responsible for meningitis. Nausea, vomiting, photophobia and altered mental status are some of the symptoms of meningitis. Vaccination can help prevent bacterial meningitis.
Reading Report Overview: https://www.transparencymarketresearch.com/meningitis-vaccine-market.html
Depending on the type of vaccine, the global meningitis vaccine market may be segmented into type b anti-haemophilus vaccine, pneumococcal conjugate virus, polysaccharide pneumococcal vaccine, meningococcal vaccine, etc. The meningococcal vaccine segment is expected to grow at a steady pace over the forecast period, as the meningococcal vaccine can protect against four clbades of bacteria that cause meningitis. The meningococcal vaccine segment can be subdivided into meningococcal conjugate vaccines and serogroup B antimicringococcal vaccines. In terms of end-user, the meningitis vaccine market can be divided into two: adults and children. The children's segment is expected to grow faster as bacterial meningitis mainly affects children. In terms of distribution channel, the global meningitis vaccine market can be segmented into hospital pharmacies, retail pharmacies, and so on. The hospital pharmacy segment is expected to grow at a significant pace over the forecast period as several types of vaccines are widely available in hospital pharmacies.
The increase in the incidence of meningitis in children is one of the main factors fueling the global market for meningitis vaccine. In addition, the risk of permanent disability in children and increased sensitization to the appropriate dose of immunization should boost the market for the meningitis vaccine. However, bacterial resistance to penicillin and lack of access to vaccine approval are likely to hinder the meningitis vaccine market in the coming years.
Request the report brochure: https: //www.transparencymarketresearch.com/sample/sample.php? Flag = B & rep_id = 40682
In terms of region, the global meningitis vaccine market can be segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. North America dominates the global market for meningitis vaccines. The region is expected to account for a significant portion of the global market for meningitis vaccines over the forecast period due to the presence of key vaccine manufacturers and vaccine awareness. Favorable government support for including vaccines such as meningococcal C conjugate vaccine (MCC) in the national routine immunization schedules of the European Center for Disease Prevention and Control for the treatment of meningitis is likely to stimulate the meningitis vaccine market in Europe. The incidence of bacterial meningitis is increasing in countries such as Thailand and North Korea. This stimulates the demand for vaccination to fight the disease, which should propel the market for meningitis vaccines in Asia-Pacific. Increased awareness of meningitis vaccination and high prevalence of bacterial meningitis is expected to strengthen the meningitis vaccine market in the Middle East and Africa during the forecast period.
The major players in the global meningitis vaccine market are GlaxoSmithKline, plc, Pfizer, Inc., Merck & Co., Inc., Sanofi Pasteur SA, Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson , MedImmune. , LLC, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Protein Sciences Corporation and Panacea Biotec, among others.
Table of contents request: https: //www.transparencymarketresearch.com/sample/sample.php? Flag = T & rep_id = 40682
About market research for transparency
Transparency Market Research (TMR) is a US-based provider of contract research, customized research and consulting services. Information on the global and regional TMR market covers sectors such as the pharmaceutical industry, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides customers with a 360-degree view of the market with statistical forecasts, a competitive landscape, detailed segmentation, key trends and strategic recommendations.
Contact us:
Market Research on Transparency
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: + 1-518-618-1030
United States – Canada toll free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
For more information on this press release, visit: http://www.sbwire.com/press-releases/meningitis-vaccine-market/release-1122621.htm
[ad_2]
Source link
